Krishna Ella
Krishna M. Ella | |
---|---|
Born | Tamil Nadu, India |
Residence | Shamirpet, Hyderabad |
Occupation | CMD at Bharat Biotech |
Website |
www |
Krishna M. Ella is an Indian entrepreneur, scientist, and founder of Bharat Biotech International Ltd, Genome Valley and Ella foundation.[1][2][3]
Ella holds M.S. from the University of Hawaii and Ph.D (1987 to 1993), from College of Agricultural Sciences, Department of Plant Pathology at University of Wisconsin, Madison, U.S.A.[4] Later, Ella held the position of assistant professor, at Medical University of South Carolina, Charleston. With expertise in yeast molecular genetics, he founded, Bharat Biotech in 1996.[5]
Awards
- National Award for ‘Best R&D Efforts in Industry' by the Department of Scientific and Industrial Research (DSIR)
- National Research Service Award
- Rotary International prize
- Indian Council of Agricultural Research Fellow
- 'Dr. K.C. Chatterjee Memorial Award' - Indian Pharmaceutical Association
- University Gold medalist for highest C.G.P.A., American Spring (ASPEE)
- Biospectrum Award
Personal life
Ella was born to a Telugu agricultural family in Tamil Nadu, India. He is married to Suchitra and has a son and a daughter.[6][7]
References
- ↑ rediff. "Genome valley history". Retrieved 2012-08-21.
- ↑ "Hyderabad foundation gets $ 100,000 grant for polio vaccine". Ibnlive.in.com. Retrieved 2012-12-06.
- ↑ "Dr.Krishna M.Ella,Bharat Biotech International Ltd". Reachouthyderabad.com. 2003-08-14. Retrieved 2011-10-09.
- ↑ "Meet the man behind India's Genome Valley - Rediff.com Business". Rediff.com. 2011-01-07. Retrieved 2012-12-06.
- ↑ "Wisconsin Alumni Association - 2011 DAA Honoree Krishna Ella". Uwalumni.com. Retrieved 2011-10-09.
- ↑ "The Hindu Business Line : Bharat Bio launches typhoid vaccines". Thehindubusinessline.in. 2003-05-10. Retrieved 2012-12-06.
- ↑ "BioSpectrumIndia - the business of biotech - BioSpectrum Awards - 2003". Biospectrumindia.ciol.com. Retrieved 2012-12-06.
This article is issued from Wikipedia - version of the 11/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.